BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25826459)

  • 21. Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
    Walter RFH; Rozynek P; Casjens S; Werner R; Mairinger FD; Speel EJM; Zur Hausen A; Meier S; Wohlschlaeger J; Theegarten D; Behrens T; Schmid KW; Brüning T; Johnen G
    PLoS One; 2018; 13(5):e0195716. PubMed ID: 29851970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens.
    Kim GE; Kweon SS; Lee JS; Lee JH; Nam JH; Choi C
    Anal Quant Cytopathol Histpathol; 2012 Aug; 34(4):195-203. PubMed ID: 23016466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.
    Clarke MA; Gradissimo A; Schiffman M; Lam J; Sollecito CC; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Castle PE; Wentzensen N; Burk RD
    Clin Cancer Res; 2018 May; 24(9):2194-2202. PubMed ID: 29420222
    [No Abstract]   [Full Text] [Related]  

  • 24. Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV.
    Wang KH; Lin CJ; Liu CJ; Liu DW; Huang RL; Ding DC; Weng CF; Chu TY
    Cancer Med; 2015 Jan; 4(1):43-55. PubMed ID: 25418975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
    Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
    Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
    Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
    Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of methylation of the promoter region of the MAL and CADM1 genes by pyrosequencing in cervical carcinoma.
    Mersakova S; Visnovsky J; Holubekova V; Nachajova M; Kudela E; Danko J; Lasabova Z
    Neuro Endocrinol Lett; 2014; 35(7):619-23. PubMed ID: 25617886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade.
    Bryant D; Tristram A; Liloglou T; Hibbitts S; Fiander A; Powell N
    J Clin Virol; 2014 Jan; 59(1):24-9. PubMed ID: 24268385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
    Kang S; Kim JW; Kang GH; Lee S; Park NH; Song YS; Park SY; Kang SB; Lee HP
    Int J Cancer; 2006 May; 118(9):2168-71. PubMed ID: 16331610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women.
    Dankai W; Khunamornpong S; Siriaunkgul S; Soongkhaw A; Janpanao A; Utaipat U; Kitkumthorn N; Mutirangura A; Srisomboon J; Lekawanvijit S
    PLoS One; 2019; 14(1):e0210289. PubMed ID: 30608989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [p16 gene CpG methylation in cervical squamous cell carcinoma and HPV16 infection in Uyghur women].
    Yuan M; Li A; Yao L; Shen G; Cheng J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 38(1):48-53. PubMed ID: 23406849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
    Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
    Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
    Wisman GB; Nijhuis ER; Hoque MO; Reesink-Peters N; Koning AJ; Volders HH; Buikema HJ; Boezen HM; Hollema H; Schuuring E; Sidransky D; van der Zee AG
    Int J Cancer; 2006 Oct; 119(8):1908-14. PubMed ID: 16736496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
    Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M
    PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
    Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
    Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDH1 promoter methylation in patients with cervical carcinoma: a systematic meta-analysis with trial sequential analysis.
    Liu G
    Future Oncol; 2018 Jan; 14(1):51-63. PubMed ID: 29237293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of
    Meršaková S; Holubeková V; Grendár M; Višňovský J; Ňachajová M; Kalman M; Kúdela E; Žúbor P; Bielik T; Lasabová Z; Danko J
    Oncol Lett; 2018 Dec; 16(6):7166-7174. PubMed ID: 30546453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
    Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
    Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion.
    Sakane J; Taniyama K; Miyamoto K; Saito A; Kuraoka K; Nishimura T; Sentani K; Oue N; Yasui W
    Diagn Cytopathol; 2015 Jun; 43(6):462-70. PubMed ID: 25614457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
    Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
    Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.